TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Galecto Biotech AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
11,499
|
0 |
| Financial expenses |
2,821
|
10,447
|
172 |
| Earnings before taxes |
-343,614
|
-528,779
|
-34,914 |
| EBITDA |
-342,940
|
-519,374
|
-35,122 |
| Total assets |
92,083
|
187,197
|
13,941 |
| Current assets |
48,222
|
134,828
|
11,104 |
| Current liabilities |
72,153
|
161,201
|
2,341 |
| Equity capital |
19,929
|
25,996
|
11,600 |
| - share capital |
2,731
|
2,557
|
237 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
21.6%
|
13.9%
|
83.2% |
| Turnover per employee |
0
|
5,750
|
0 |
| Profit as a percentage of turnover | -4598.5% | ||
| Return on assets (ROA) |
-370.1%
|
-276.9%
|
-249.2% |
| Current ratio |
66.8%
|
83.6%
|
474.3% |
| Return on equity (ROE) |
-1724.2%
|
-2034.1%
|
-301.0% |
| Change turnover |
-12,314
|
11,499
|
0 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
0
|
1 |
| Chg. No. of employees % |
0%
|
0%
|
100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.